TAK 875
http://www.ama-assn.org/resources/doc/usan/fasiglifam.pdf GET CAS NO STR MW, ETC HERE
Takeda Pharmaceutical Co has presented positive late-stage data on a new diabetes compound called fasiglifam.
The company announced results of a Phase III trial at the Japan Diabetes Society meeting in Kumamoto,
read all at
